These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

590 related articles for article (PubMed ID: 9400788)

  • 21. Multicenter clinical trial for evaluating methylprednisolone pulse treatment of idiopathic optic neuritis in Japan. Optic Neuritis Treatment Trial Multicenter Cooperative Research Group (ONMRG).
    Wakakura M; Mashimo K; Oono S; Matsui Y; Tabuchi A; Kani K; Shikishima K; Kawai K; Nakao Y; Tazawa Y; Kiyosawa M; Abe H; Ohba N; Yago K; Maeda S; Sugita M; Ishikawa S
    Jpn J Ophthalmol; 1999; 43(2):133-8. PubMed ID: 10340796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optic neuritis treatment trial. One-year follow-up results.
    Beck RW; Cleary PA
    Arch Ophthalmol; 1993 Jun; 111(6):773-5. PubMed ID: 8512477
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Optic neuritis: clinical analysis of 27 cases.
    Bee YS; Lin MC; Wang CC; Sheu SJ
    Kaohsiung J Med Sci; 2003 Mar; 19(3):105-12. PubMed ID: 12751870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Comparative treatment of acute optic neuritis with "boluses" of intravenous methylprednisolone or oral prednisone].
    Alejandro PM; Castañón González JA; Miranda Ruiz R; Edgar Echeverria R; Adriana Montãno M
    Gac Med Mex; 1994; 130(4):227-30. PubMed ID: 8964329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optic neuritis associated with chikungunya virus infection in South India.
    Mittal A; Mittal S; Bharati MJ; Ramakrishnan R; Saravanan S; Sathe PS
    Arch Ophthalmol; 2007 Oct; 125(10):1381-6. PubMed ID: 17923547
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poor prognosis of visual outcome after visual loss from giant cell arteritis.
    Danesh-Meyer H; Savino PJ; Gamble GG
    Ophthalmology; 2005 Jun; 112(6):1098-103. PubMed ID: 15885780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial.
    Beck RW; Gal RL
    Arch Ophthalmol; 2008 Jul; 126(7):994-5. PubMed ID: 18625951
    [No Abstract]   [Full Text] [Related]  

  • 28. Critical flicker frequency in acute and recovered optic neuritis.
    Woung LC; Wakakura M; Ishikawa S
    Jpn J Ophthalmol; 1993; 37(2):122-9. PubMed ID: 8230835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Residual symptoms and signs after untreated acute optic neuritis. A one-year follow-up.
    Frederiksen JL; Sørensen TL; Sellebjerg FT
    Acta Ophthalmol Scand; 1997 Oct; 75(5):544-7. PubMed ID: 9469554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Visual functions in optic neuritis].
    Jirásková N; Rozsíval P
    Cesk Slov Oftalmol; 2004 Nov; 60(6):394-9. PubMed ID: 15745407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The dyschromatopsia of optic neuritis: a descriptive analysis of data from the optic neuritis treatment trial.
    Katz B
    Trans Am Ophthalmol Soc; 1995; 93():685-708. PubMed ID: 8719696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of optic neuritis by plasma exchange (add-on) in neuromyelitis optica.
    Merle H; Olindo S; Jeannin S; Valentino R; Mehdaoui H; Cabot F; Donnio A; Hage R; Richer R; Smadja D; Cabre P
    Arch Ophthalmol; 2012 Jul; 130(7):858-62. PubMed ID: 22776923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis.
    Fernandes DB; Ramos Rde I; Falcochio C; Apóstolos-Pereira S; Callegaro D; Monteiro ML
    J Neuroophthalmol; 2012 Jun; 32(2):102-6. PubMed ID: 22157535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Short-term effect of megadose steroid therapy in optic neuritis].
    Gerling J; Kommerell G
    Klin Monbl Augenheilkd; 1992 Dec; 201(6):375-80. PubMed ID: 1287359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The course of visual recovery after optic neuritis. Experience of the Optic Neuritis Treatment Trial.
    Beck RW; Cleary PA; Backlund JC
    Ophthalmology; 1994 Nov; 101(11):1771-8. PubMed ID: 7800355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrobulbar optic neuritis and live attenuated influenza vaccine.
    Crawford CM; Grazko MB; Raymond WR; Rivers BA; Munson PD
    J Pediatr Ophthalmol Strabismus; 2013; 50(1):61. PubMed ID: 23343091
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind, randomized trial of IV immunoglobulin treatment in acute optic neuritis.
    Roed HG; Langkilde A; Sellebjerg F; Lauritzen M; Bang P; Mørup A; Frederiksen JL
    Neurology; 2005 Mar; 64(5):804-10. PubMed ID: 15753413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optic neuritis treatment trial:10-year follow-up results.
    Chan CK; Lam DS
    Am J Ophthalmol; 2004 Oct; 138(4):695; author reply 695. PubMed ID: 15488834
    [No Abstract]   [Full Text] [Related]  

  • 39. What we have learned from the Optic Neuritis Treatment Trial.
    Beck RW; Trobe JD
    Ophthalmology; 1995 Oct; 102(10):1504-8. PubMed ID: 9097798
    [No Abstract]   [Full Text] [Related]  

  • 40. [Visual functions of optic neuritis in children caused by demyelinating disease].
    Miyazaki I
    Nippon Ganka Gakkai Zasshi; 1991 Oct; 95(10):995-1003. PubMed ID: 1746376
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.